School of Medicine
Showing 1-100 of 387 Results
-
Raj Fadadu
Casual - Non-Exempt, Epidemiology and Population Health
BioRaj Fadadu is currently a dermatology resident physician at the University of California, San Diego. He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) as well as epigenetics (e.g., EWAS and epigenetic age acceleration). At Stanford, his research in Dr. Andres Cardenas's group focuses on the relationship between environmental exposures and epigenetic modifications. He also held leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.
He received a M.D. from UC San Francisco, M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health, and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors). -
Muneeb A. Faiq
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioDr. Muneeb A. Faiq is a behavioral and metabolic neuroscientist and ophthalmology researcher whose work spans molecular biology, neuroimaging, and systems neuroscience. He has made several foundational contributions, including the first functional cloning of CYP1B1 in congenital glaucoma, implicating retinoic-acid signaling in Zika virus–associated microcephaly, identifying central insulin resistance as a mechanistic basis for glaucoma, and providing the first in vivo evidence for a glymphatic pathway in the optic nerve. With more than 100 peer-reviewed publications and over 4,000 citations, Dr. Faiq has earned international recognition, including the Emerging Vision Scientist Award – 2019 from the Alliance for Eye and Vision Research. He is widely regarded as the pioneer and principal architect of the discipline of psychosomatic ophthalmology, a field he helped conceptualize and establish, leading to the integration of ophthalmic clinical practice with mindfulness-based and psychosomatic medicine frameworks. Dr. Faiq is currently advancing the concept of neurometabolic syntax in vision and brain function — a unifying systems-level framework that integrates genetics, metabolism, and behavior to reconceptualize ophthalmic and neurological diseases through a mechanistic and interdisciplinary lens. He has been selected for the prestigious Asia Pacific Academy of Ophthalmology (APAO) Achievement Award 2026.
-
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research focuses on musculoskeletal and organ-based ultrasound in rheumatic disease, including arthritis, calcinosis, vascular pathology, and interstitial lung disease. He develops ultrasound-based outcome measures and leads projects applying deep learning and explainable AI to imaging. He also performs ultrasound-guided synovial biopsies to support translational and clinical research.
-
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
BioDr. Bita Fakhri is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford. Additionally, in her role as the DEI ambassador of the Division of Hematology, her main focus is to enhance trial equity among underserved and marginalized populations in the Stanford catchment area.
-
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Ryann Fame, PhD
Assistant Professor of Neurosurgery
Current Research and Scholarly InterestsEarly neural progenitors respond to extrinsic cues that maintain and support their potency. These stem/ progenitor cells are in direct contact with the cerebrospinal fluid (CSF), which acts as part of their niche. Our research program encompasses the early neural stem cell niche, neural tube closure, CSF, metabolism, and cortical neuronal development. We are dedicated to broad collaboration focused on translating an understanding of neurodevelopment and CSF biology into regenerative strategies.
-
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Richard E. Fan
Clinical Associate Professor, Urology
BioRichard E. Fan, Ph.D., is an engineer embedded in the Department of Urology in the Stanford School of Medicine.
Dr. Fan’s research relates to the development of clinically driven biomedical instrumentation and medical devices. He is interested in translational application of emerging technologies in the medical and surgical spaces, as well as the development of platforms to explore clinical and pre-clinical evaluation. His primary work is currently focused on image guided detection and treatment of prostate cancer, including MR-US fusion, focal therapies, embedded systems and robotics. -
Daniel Z Fang
Affiliate, Med/Hospital Medicine
BioDaniel Z Fang, MD, FACP completed his medical school training at UC San Diego School of Medicine and residency at Stanford University. He is a board-certified academic hospitalist at the VA Palo Alto Health Care System and Clinical Associate Professor (Affiliated) within the Stanford Division of Hospital Medicine.
As Assistant DCOS for Acute Care Hospital Operations, he provides administrative and clinical guidance to clinical service staff in the areas of inpatient performance, patient flow optimization, policy review, project planning, and process improvement initiatives. His professional interests include healthcare administration and quality improvement. -
Rongxin Fang
Assistant Professor of Neurosurgery and, by courtesy, of Genetics
BioRongxin Fang received his Ph.D. in Bioinformatics and Systems Biology from the University of California, San Diego, under the mentorship of Bing Ren (2015–2019). During his doctoral training, he developed high-throughput genomic technologies and computational tools to map the structure and activity of the mammalian genome at large scale and single-cell resolution. He then applied these approaches to investigate how cis-regulatory elements - such as enhancers - control gene expression and drive the diverse transcriptional programs underlying cellular diversity in the mammalian brain. As an HHMI–Damon Runyon Postdoctoral Fellow at Harvard University (2019–2024), he worked with Xiaowei Zhuang. Rongxin developed and applied genome-scale, volumetric 3D transcriptome imaging methods to map the molecular and cellular architecture of the mammalian brain across evolution and aging. He also contributed to the collaboration with Adam Cohen and Catherine Dulac to integrate transcriptome imaging with functional neuronal imaging, identifying neuronal populations in the animal brain that underlie specific brain functions.
-
Zhongnan Fang
Affiliate, Rad/Radiology Finance and Administration
BioDr. Fang is a Principal ML Scientist in the AIDE Lab. His research interests lie in driving AI innovations in medicine, with a focus on AI model design and development, performance and robustness evaluation, and quality monitoring and debugging. Previously, he was a founding member and the Data Science Lead at LVIS corporation, pioneering personalized neurological disease treatment using cutting-edge neuroscience findings and AI technologies.
-
James Fann
Professor of Cardiothoracic Surgery (Adult Cardiac Surgery) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiac surgery education and simulation-based learning, coronary artery bypass surgery, cardiac valve disease
-
Gary S. Fanton, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Gary Fanton is the Chief of the Section of Sports Medicine at Stanfords Department of Orthopedic Surgery. His practice primarily involves the diagnostic evaluation and treatment of sports and trauma-related injuries of the upper extremity, knee, and ankle. He is Board Certified by the American Board of Orthopedic Surgery and is currently the Team Physician in Orthopedics for the San Francisco 49ers. Dr. Fanton's past experience includes positions as team orthopedist for the San Francisco Giants, company physician for the San Jose Ballet, head team orthopedist for Stanford University football and basketball, and team orthopedist for Stanfords additional 29 varsity sports. He co-founded the SOAR clinic where he was an active partner in private practice since 1983. He holds a B.S. degree from the University of Michigan and M.D. degree from the Medical College of Wisconsin.
Dr. Fanton's special interests include arthroscopic surgery of the knee and shoulder...specifically, injuries to the anterior cruciate ligament of the knee, cartilage injuries, rotator cuff tears, and shoulder instability. He has done extensive research on knee ligament tears, explored new techniques for shoulder stabilization and tendon repair, and he utilizes state-of-the-art surgical procedures to enhance rehabilitation and recovery after surgery. He is frequently asked to be a guest lecturer both nationally and internationally on these and other sports-medicine related topics. He has also authored dozens of articles on sports injuries and new surgical techniques.
Dr. Fanton was a co-founder and board member of Oratec Interventions, a medical device start-up for minimally invasive spine and joint procedures that went public in April, 2000, which was subsequently purchased by Smith-Nephew in 2002. He actively serves on the medical advisory board for several public and private surgical device companies in the Orthopedic industry and he continues to design and develop unique surgical devices for minimally invasive surgery. He has co-authored several device patents and has several others pending.
Dr. Fanton has been a member in good standing with the American Academy of Orthopedic surgeons since 1985 and he is a Diplomat of the American Board of Orthopedic Surgery. He is also member of the Orthopedic Research Society, NFL Team Physicians Society, the American Orthopedic Society of Sports Medicine, The International Knee Society, International Cartilage Repair Society, and a founding member of the International Musculoskeletal Laser Society. -
Mani Ardalan Farhadi
Facilities Senior Planner, School of Medicine - Office of Facilities Planning & Management
Current Role at StanfordAs Senior Facilities Planner in the OFPM (Office of Facilities, Planning and Management) for the SoM (School of Medicine), I collaborate with Dept. Chairs, Faculty, Researchers, Staff and Facilities to optimize layouts for appx. 2M square feet of space as adjustments are needed to offices, labs, and teaching spaces across the campuses of Stanford University. I work with consultants, designers, project managers, furniture vendors, movers and others to determine the optimal solutions. After 30+ years of being in architectural firms working with educational institutions, I'm thrilled to be inside that setting and contributing to the success of the School of Medicine.
-
Diana Farid
Clinical Associate Professor, Medicine - Vaden Health Center
BioDiana Farid MD, MPH is a physician, filmmaker, an award-winning author and poet. She is a Clinical Associate Professor in the Department of Medicine and Faculty in the Medical Humanities and Arts Program at Stanford's School of Medicine. After earning a BA in Peace and Conflict Studies at UC Berkeley, MD at Northwestern University, and Family Medicine specialty training at UCLA, she was awarded a U.S. Department of Health and Human Services Child and Family Health Leadership Fellowship, during which she earned a Masters in Public Health focused on community health and storytelling.
Since then, Diana has continued to care for patients while creating and championing the vital role of story and the arts in medicine and health. After serving as a physician consultant for television shows like Grey's Anatomy, she produced the feature length documentary film, American Rhythms, exploring the positive impact of music on elementary school student health. At Stanford, she has integrated medicine and the mediums of film, creative writing, and poetry into student and community experiences while leading and presenting arts programs across Stanford. As Assistant Director of Stanford School of Medicine’s Program in Bioethics and Film, she produced film screenings and panel discussions exploring films with vital bioethical implications. She established the first Stanford Film and Medicine Interest group for medical students to study film as a health promotion tool and has mentored medical student film projects. She produced the Stanford Medicine and the Muse, Medical Humanities and the Arts' 2018 Frankenstein@200 year-long cross-campus film screening and panel series.
Her poetry has been featured in gallery exhibits, storytelling events, anthologies, and journals. Her multi-award-winning picture book, When You Breathe (Abrams), melds respiratory science with poetry. Her novel written in verse, Wave (Abrams), celebrating medicine, music and poetry and noted as “Raw and powerful…Rich, layered and heart-rending” — Kirkus, has won numerous awards including the Cybils Award for Novel in Verse, was named a Best Middle Grade Book of 2022 by the School Library Journal, and is on state education board reading lists across the United States. Her latest picture book, The Light of Home (Scholastic) is a lyrical story about painting and belonging. Her debut board book Already All the Love (Little Bee Books) is a poem for presence. She is an Editorial Board Member for poetry for the medical humanities journal, The Pharos. In 2025, she created a first-of-its-kind Women in Medicine participatory poem for the Stanford School of Medicine. In 2026, she is co-teaching Peds 129: Little Libraries: Improving Children’s Literacy through Service and Storytelling. For 2025-2026, she is one of the inaugural artsCatalyst Fellows of the Stanford Arts Institute. -
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly InterestsMy lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
-
Mohsen Fathzadeh
Genomic Scientist, Institute For International Studies, Loyalka, Prashant's Program
BioMohsen Fathzadeh is a medical geneticist with 20+ years of experience bridging science, care, and innovation.
His academic journey began at Yale University, where he completed his Ph.D. thesis under Prof. Arya Mani, focusing on a genetic form of familial Metabolic Syndrome. From 2015 to 2021, he served as a Postdoctoral Fellow at Stanford University, specializing in Cardiovascular Medicine, Psychiatry, and Public Health Sciences. During this tenure, he conducted comprehensive functional genomic analyses under the mentorship of esteemed professors.
Mohsen's collaborative efforts with Merck & Co., Inc. led to the identification of a gene regulator associated with body fat distribution. His research scope also includes the characterization of genes linked to insulin resistance and obesity. Recently, he explored the (epi)genetic link between newborn body fat distribution and high maternal gestational glucose levels, focusing on mother-child cohorts from diverse and underserved communities.
His primary goal is to utilize his findings to enhance our understanding of the genes and evolutionary pathways influencing healthspan and age-related diseases, thereby improving patient lives.
After completing his postdoctoral research in 2021, Mohsen spent two years in the biotech industry, specializing in genetic testing and variant assessment. He has an ongoing research project with Stanford's Population Health Center, studying epigenetic disease mechanisms in mother-child cohorts.
Mohsen recently joined Stanford's Graduate School of Education and the Freeman Spogli Institute for International Studies to work with Prof. Prashant Loyalka on a pioneering study that explores how educational interventions in genetic counseling can empower families—particularly in the context of autism spectrum disorders. This new chapter reflects his deepening commitment to integrating genomic science with public health education, leveraging AI and evidence-based learning to promote equity, early intervention, and informed decision-making across diverse populations. As the field of genetic counseling evolves, Mohsen envisions a future where accessible education and responsible innovation in educational AI can help every individual—and every story—be seen, heard, and supported.
Outside his professional life, Mohsen leads an active lifestyle and enjoys learning about diverse cultures. -
William O Faustman
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training, administration, forensic practice, and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition and clinical assessment.. He serves as a member of the Stanford IRB and coordinates the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,
-
Zoha Zahid Fazal
Visiting Instructor, Ophthalmology Research/Clinical Trials
BioZoha Zahid Fazal is a postdoctoral research fellow at the Sepah Lab at Stanford Medicine, where her work advances screening innovation and diagnostic automation for retinal degenerative diseases through cutting-edge research and artificial intelligence–driven tools. During her time at Stanford, she has collaborated across the Spencer Center for Vision Research, the Center for Digital Health, the Center for Artificial Intelligence in Medicine and Imaging, the Ocular Imaging Research & Reading Center, and the Mussallem Center for Biodesign—developing a multidisciplinary skill set at the intersection of medicine, applied coding, and computation.
Previously, as a predoctoral scholar, Zoha worked closely with the Director of the Global Health Dermatology Program at Yale School of Medicine, contributing to global training, research, advocacy, and field-based interventions addressing tropical and culturally contextual dermatologic disease. She also gained clinical and research experience through the Northwestern Medicine Adjunct Dermatology Program, supporting patient care, clinical education, and research in skin-of-color dermatology, autoimmune disease, and complex dermatopathies. Through these roles, she helped establish collaborative research initiatives linking U.S. academic centers with her home medical school in Pakistan.
Zoha earned her medical degree from Aga Khan University, graduating with honors in Community Health Sciences, and is recognized for her leadership and impact in community service. As part of AKU’s community education efforts during the COVID-19 pandemic, she co-authored and edited 'How Not to Go Viral', a student handbook, over 1,500 copies of which were distributed to libraries across Pakistan. For her contributions to poverty alleviation and pandemic relief efforts, she was awarded the Quadragon Member of the Year Award in 2020. She has also volunteered extensively in flood-relief operations and rural medical camps across Pakistan, experiences that exposed her to the limitations of resource-constrained health systems and paper-based medical records.
Zoha’s interest in global health research and big-data analytics began early. She graduated with distinction from Cedar College, majoring in biological sciences and advanced mathematics, and spent formative summers working alongside nursing faculty and public health leaders at the institution that later became her medical school. She has since continued to build technical fluency in healthcare data analytics and research software through self-directed coursework. She served as a global research lead from Pakistan for the COVAD Collaborative, led by the NHS Foundation Trust (UK), where her work focused on patient safety, healthcare quality, and vaccine uptake among individuals with autoimmune diseases. As a medical student, she also led Gates Foundation–sponsored interventional studies aimed at improving maternal, neonatal, and child health outcomes in underserved settings.
Looking ahead, Zoha envisions a career as a clinician-scientist specializing in biomedical informatics. Her long-term goal is to design sustainable, scalable, and context-aware digital health systems for developing nations—systems that are grounded in local resources, cultural realities, and environmental constraints. Through human-centered digital health innovation, she aims to advance equitable, evidence-based care globally. -
William Fearon, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
-
Palmer Feibelman
Postdoctoral Scholar, Ophthalmology
BioPalmer Feibelman studied biomedical engineering at Georgia Tech before earning his medical degree from the Medical College of Georgia. He went on to serve as a medical officer in the U.S. Navy, where he held the role of Medical Department Head at Navy Operational Support Center Washington, D.C., and later deployed as a flight surgeon with Marine F/A-18 squadron VMFA-232. Following his military service, he pursued ophthalmology training at Brown University, where he also continued to build on his engineering background. He is now the Ophthalmology Innovation Fellow at Stanford University for the 2025–2026 academic year.
-
Jeffrey A. Feinstein, MD, MPH
Dunlevie Family Professor of Pulmonary Vascular Disease and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsResearch interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular diseases, and (3) development and testing of medical devices/therapies for the treatment of congenital heart disease and pulmonary vascular diseases.
-
David Feldman
Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsStudies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.
-
Heidi M. Feldman
Ballinger-Swindells Endowed Professor of Developmental and Behavioral Pediatrics
Current Research and Scholarly InterestsMy current research program focuses on infants born preterm, before 32 weeks gestation from two language environments: English and Spanish. The study considers how neurobiological factors, specifically properties of the white matter circuits in the brain, interact with social, psychological, and economic factors to predict language processing efficiency at 18 months of age.
-
Marcus Feldman
Burnet C. and Mildred Finley Wohlford Professor
Current Research and Scholarly InterestsHuman genetic and cultural evolution, mathematical biology, demography of China
